Procter & Gamble Health Limited (PGHL) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.278x

Based on the latest financial reports, Procter & Gamble Health Limited (PGHL) has a cash flow conversion efficiency ratio of 0.278x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.72 Billion ≈ $18.63 Million USD) by net assets (Rs6.20 Billion ≈ $67.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Procter & Gamble Health Limited (PGHL) market capitalisation for the company's overall valuation and market capitalisation.

Procter & Gamble Health Limited - Cash Flow Conversion Efficiency Trend (2003–2024)

This chart illustrates how Procter & Gamble Health Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Procter & Gamble Health Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Procter & Gamble Health Limited ranked by their cash flow conversion efficiency. Explore PGHL operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Nsfocus Information Technology Co Ltd
SHE:300369
-0.005x
Shenzhen Minkave Technology Co Ltd
SHE:300506
0.013x
National Presto Industries Inc
NYSE:NPK
0.079x
TWO HARBORS INV. DL-0001
F:2H2
0.066x
HyUnion Holding Co Ltd
SHE:002537
0.017x
AMAG Austria Metall AG
VI:AMAG
0.035x
BlackRock Technology and Private Equity Term Trust
NYSE:BTX
-0.007x
Sinosteel Anhui Tianyuan Technology Co Ltd
SHE:002057
0.015x

Annual Cash Flow Conversion Efficiency for Procter & Gamble Health Limited (2003–2024)

The table below shows the annual cash flow conversion efficiency of Procter & Gamble Health Limited from 2003 to 2024. View current stock price of Procter & Gamble Health Limited for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rs5.37 Billion
≈ $58.07 Million
Rs1.76 Billion
≈ $19.02 Million
0.327x -22.79%
2023-12-31 Rs5.38 Billion
≈ $58.21 Million
Rs2.28 Billion
≈ $24.69 Million
0.424x +34.94%
2022-12-31 Rs7.51 Billion
≈ $81.21 Million
Rs2.36 Billion
≈ $25.52 Million
0.314x +14.30%
2021-12-31 Rs6.16 Billion
≈ $66.67 Million
Rs1.70 Billion
≈ $18.33 Million
0.275x -21.74%
2020-12-31 Rs7.04 Billion
≈ $76.10 Million
Rs2.47 Billion
≈ $26.74 Million
0.351x +7.61%
2019-12-31 Rs9.06 Billion
≈ $98.02 Million
Rs2.96 Billion
≈ $32.00 Million
0.327x +485.69%
2018-12-31 Rs15.40 Billion
≈ $166.56 Million
Rs-1.30 Billion
≈ $-14.10 Million
-0.085x -215.68%
2017-12-31 Rs7.33 Billion
≈ $79.30 Million
Rs536.60 Million
≈ $5.80 Million
0.073x -55.87%
2016-12-31 Rs6.45 Billion
≈ $69.80 Million
Rs1.07 Billion
≈ $11.58 Million
0.166x +17.26%
2015-12-31 Rs5.92 Billion
≈ $63.97 Million
Rs836.60 Million
≈ $9.05 Million
0.141x +1483.68%
2014-12-31 Rs5.54 Billion
≈ $59.95 Million
Rs49.50 Million
≈ $535.32K
0.009x +937.95%
2013-12-31 Rs5.23 Billion
≈ $56.56 Million
Rs4.50 Million
≈ $48.67K
0.001x -99.23%
2012-12-31 Rs4.84 Billion
≈ $52.31 Million
Rs542.60 Million
≈ $5.87 Million
0.112x +280.13%
2011-12-31 Rs4.10 Billion
≈ $44.35 Million
Rs-255.40 Million
≈ $-2.76 Million
-0.062x -132.70%
2010-12-31 Rs3.46 Billion
≈ $37.46 Million
Rs659.70 Million
≈ $7.13 Million
0.190x +113.20%
2009-12-31 Rs4.67 Billion
≈ $50.54 Million
Rs417.40 Million
≈ $4.51 Million
0.089x +936.50%
2008-12-31 Rs4.51 Billion
≈ $48.82 Million
Rs38.90 Million
≈ $420.69K
0.009x -90.44%
2007-12-31 Rs4.23 Billion
≈ $45.74 Million
Rs381.10 Million
≈ $4.12 Million
0.090x -56.34%
2006-12-31 Rs3.93 Billion
≈ $42.50 Million
Rs811.20 Million
≈ $8.77 Million
0.206x -20.21%
2005-12-31 Rs2.98 Billion
≈ $32.24 Million
Rs771.20 Million
≈ $8.34 Million
0.259x -18.21%
2004-12-31 Rs2.48 Billion
≈ $26.84 Million
Rs784.90 Million
≈ $8.49 Million
0.316x -14.07%
2003-12-31 Rs1.96 Billion
≈ $21.22 Million
Rs722.30 Million
≈ $7.81 Million
0.368x --

About Procter & Gamble Health Limited

NSE:PGHL India Drug Manufacturers - Specialty & Generic
Market Cap
$987.97 Million
Rs91.35 Billion INR
Market Cap Rank
#9009 Global
#441 in India
Share Price
Rs5503.50
Change (1 day)
+1.27%
52-Week Range
Rs4778.60 - Rs6918.50
All Time High
Rs6918.50
About

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter … Read more